Over the last 12 months, Medline insiders reported 4 buys totaling $515.0M and 30 sales totaling $13.87B across SEC Form 4 filings. 6% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | GIC Private Ltd10% | ▼ Sale | 1,600,000 | $35.8 | $57.3M | -6.6% | 2 tranches |
| Aug 7, 2026 | GIC Private Ltd10% | ▼ Sale | 590,284 | $35.58 | $21.0M | -2.4% | — |
| Aug 6, 2026 | GIC Private Ltd10% | ▼ Sale | 2,248,612 | $35.56 | $80.0M | -8.3% | 3 tranches |
| Jun 16, 2026 | Golwas Douglas PChief Commercial Officer · O·10% | ▽ Sale to issuer | 100,000 | — | — | -21.5% | plan |
| Jun 16, 2026 | Golwas Douglas PChief Commercial Officer · O·10% | ▼ Sale | 100,000 | $36.77 | $3.7M | -80.7% | plan · 2 tranches |
| Jun 5, 2026 | CORCORAN JESSI LPrincipal Accounting Officer · O | ▲ Buy | 5,000 | $34.15 | $171K | — | — |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 1,262,726 | $36.54 | $46.1M | -16.2% | indirect |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 11,904,646 | $36.54 | $435.0M | -16% | indirect |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 753,528 | $36.54 | $27.5M | -18% | indirect |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 17,947,337 | $36.54 | $655.8M | -98.7% | indirect |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C.10% | ▼ Sale | 1,489,924 | $36.54 | $54.4M | -99.9% | indirect |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C.10% | ▼ Sale | 2,256,800 | $36.54 | $82.5M | -18% | indirect |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C.10% | ▼ Sale | 9,858,774 | $36.54 | $360.2M | -99.9% | indirect |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C.10% | ▼ Sale | 19,712,326 | $36.54 | $720.2M | -18% | indirect |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P.10% | ▼ Sale | 1,489,924 | $36.54 | $54.4M | -99.9% | indirect |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P.10% | ▼ Sale | 2,256,800 | $36.54 | $82.5M | -18% | indirect |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P.10% | ▼ Sale | 9,858,774 | $36.54 | $360.2M | -99.9% | indirect |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P.10% | ▼ Sale | 19,712,326 | $36.54 | $720.2M | -18% | indirect |
| Mar 10, 2026 | Carlyle Group Inc.10% | ▼ Sale | 26,105,840 | $41 | $1.07B | -17% | indirect |
| Mar 10, 2026 | Carlyle Mozart Coinvestment Holdings, L.P.10% | ▼ Sale | 26,105,840 | $41 | $1.07B | -17% | indirect |
| Mar 10, 2026 | CP Circle ML Holdco GP, LLC10% | ▼ Sale | 26,105,840 | $41 | $1.07B | -17% | indirect |
| Mar 10, 2026 | TC Group Cayman Investment Holdings, L.P.10% | ▼ Sale | 26,105,840 | $41 | $1.07B | -17% | indirect |
| Mar 10, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 26,131,237 | $40.51 | $1.06B | -76.8% | 4 tranches · indirect |
| Mar 10, 2026 | BCP 8 Holdings Mozart Manager L.L.C.10% | ▼ Sale | 27,852,986 | $40.51 | $1.13B | -100% | 4 tranches · indirect |
| Mar 10, 2026 | BX Mozart ML-2 Holdco L.P.10% | ▼ Sale | 27,852,986 | $40.51 | $1.13B | -100% | 4 tranches · indirect |
| Dec 18, 2025 | TC Group VII S1, L.L.C.10% | ▼ Sale | 19,136,333 | $29 | $555.0M | -11.6% | indirect |
| Dec 18, 2025 | Carlyle Mozart Coinvestment Holdings, L.P.10% | ▼ Sale | 19,136,333 | $29 | $555.0M | -11.6% | indirect |
| Dec 18, 2025 | Carlyle Group Inc.10% | ▼ Sale | 19,136,333 | $29 | $555.0M | -11.6% | indirect |
| Dec 18, 2025 | Hellman & Friedman Capital Partners X (Parallel), L.P.10% | ▼ Sale | 6,088,371 | $28.37 | $172.7M | -55.9% | 3 tranches · indirect |
| Dec 18, 2025 | GIC Private Ltd10% | ▲ Buy | 12,586,206 | $29 | $365.0M | +85.9% | — |
| Dec 18, 2025 | GIC Private Ltd10% | ▼ Sale | 10,204,351 | $28.37 | $289.5M | -10% | indirect |
| Dec 18, 2025 | Mozart Aggregator II LP10% | ▼ Sale | 13,462,600 | $28.37 | $381.9M | -8.6% | indirect |
| Dec 18, 2025 | Mills Andrew J.D | ▲ Buy | 2,586,206 | $29 | $75.0M | — | indirect |
| Dec 18, 2025 | Mills Charles N.D | ▲ Buy | 2,579,310 | $29 | $74.8M | — | 2 tranches · indirect |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Medline filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MDLN feed.